GBS (GBS) Competitors $1.23 +0.08 (+6.96%) As of 04/9/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock GBS vs. NSPR, SRTS, ICCM, INO, GUTS, CTSO, ICAD, MBOT, APYX, and TELAShould you be buying GBS stock or one of its competitors? The main competitors of GBS include InspireMD (NSPR), Sensus Healthcare (SRTS), IceCure Medical (ICCM), Inovio Pharmaceuticals (INO), Fractyl Health (GUTS), Cytosorbents (CTSO), iCAD (ICAD), Microbot Medical (MBOT), Apyx Medical (APYX), and TELA Bio (TELA). These companies are all part of the "surgical & medical instruments" industry. GBS vs. InspireMD Sensus Healthcare IceCure Medical Inovio Pharmaceuticals Fractyl Health Cytosorbents iCAD Microbot Medical Apyx Medical TELA Bio GBS (NYSE:GBS) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, media sentiment, profitability, institutional ownership, community ranking, valuation and earnings. Does the MarketBeat Community prefer GBS or NSPR? InspireMD received 4 more outperform votes than GBS when rated by MarketBeat users. CompanyUnderperformOutperformGBSN/AN/AInspireMDOutperform Votes44.12%Underperform Votes9395.88% Which has more volatility and risk, GBS or NSPR? GBS has a beta of 1.32, suggesting that its stock price is 32% more volatile than the S&P 500. Comparatively, InspireMD has a beta of 0.74, suggesting that its stock price is 26% less volatile than the S&P 500. Does the media refer more to GBS or NSPR? In the previous week, GBS had 2 more articles in the media than InspireMD. MarketBeat recorded 4 mentions for GBS and 2 mentions for InspireMD. InspireMD's average media sentiment score of 0.41 beat GBS's score of 0.41 indicating that InspireMD is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GBS 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral InspireMD 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend GBS or NSPR? InspireMD has a consensus target price of $4.75, indicating a potential upside of 85.55%. Given InspireMD's stronger consensus rating and higher possible upside, analysts clearly believe InspireMD is more favorable than GBS.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GBS 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00InspireMD 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is GBS or NSPR more profitable? GBS has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat GBS's return on equity.Company Net Margins Return on Equity Return on Assets GBSN/A -85.64% -54.42% InspireMD -413.96%-69.42%-57.68% Do insiders & institutionals believe in GBS or NSPR? 2.8% of GBS shares are owned by institutional investors. Comparatively, 44.8% of InspireMD shares are owned by institutional investors. 0.3% of GBS shares are owned by insiders. Comparatively, 29.7% of InspireMD shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has higher earnings and valuation, GBS or NSPR? GBS has higher earnings, but lower revenue than InspireMD. InspireMD is trading at a lower price-to-earnings ratio than GBS, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGBS$440K41.62-$8.31M-$0.56-2.20InspireMD$7.01M10.84-$19.92M-$0.78-3.28 SummaryInspireMD beats GBS on 9 of the 17 factors compared between the two stocks. Remove Ads Get GBS News Delivered to You Automatically Sign up to receive the latest news and ratings for GBS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GBS vs. The Competition Export to ExcelMetricGBSSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$7.05M$4.06B$5.25B$18.30BDividend YieldN/A44.86%5.34%4.13%P/E Ratio-2.2027.5821.3630.70Price / Sales41.6245.68366.3325.88Price / CashN/A51.0838.1517.55Price / Book2.805.736.284.25Net Income-$8.31M$67.09M$3.19B$1.02B7 Day Performance-8.89%0.24%0.66%1.34%1 Month Performance-43.58%-8.50%-11.11%-7.29%1 Year Performance-63.28%8.15%4.51%-1.36% GBS Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GBSGBSN/A$1.23+7.0%N/A-63.3%$7.05M$440,000.00-2.207NSPRInspireMD2.0693 of 5 stars$2.70+0.4%$4.75+75.9%+11.3%$79.27M$7.01M-3.5650Analyst ForecastGap DownSRTSSensus Healthcare1.8723 of 5 stars$4.80+1.4%$13.00+171.1%+46.8%$78.68M$41.81M11.9340ICCMIceCure Medical2.8917 of 5 stars$1.25+6.3%$2.50+100.0%-10.0%$69.38M$3.29M-4.3160Gap UpINOInovio Pharmaceuticals3.7502 of 5 stars$1.60-2.1%$12.20+664.9%-86.3%$58.48M$217,756.00-0.40320GUTSFractyl Health1.9279 of 5 stars$1.18-1.3%$10.00+751.1%-85.3%$57.48M$93,000.00-0.10102Positive NewsCTSOCytosorbents2.1086 of 5 stars$1.02+2.0%$4.67+357.5%+7.4%$55.77M$33.79M-2.83220Analyst ForecastICADiCAD0.4634 of 5 stars$2.06flatN/A+4.7%$54.67M$19.61M-15.85140MBOTMicrobot Medical1.6375 of 5 stars$1.50-1.0%$9.00+502.0%+106.5%$52.29MN/A-1.8820Analyst ForecastNews CoverageGap UpAPYXApyx Medical1.9233 of 5 stars$1.29-5.8%N/A-37.7%$48.94M$48.10M-1.56270Positive NewsGap UpTELATELA Bio2.2756 of 5 stars$1.26+2.9%$7.25+477.7%-80.2%$48.80M$69.30M-0.73120 Remove Ads Related Companies and Tools Related Companies InspireMD Alternatives Sensus Healthcare Alternatives IceCure Medical Alternatives Inovio Pharmaceuticals Alternatives Fractyl Health Alternatives Cytosorbents Alternatives iCAD Alternatives Microbot Medical Alternatives Apyx Medical Alternatives TELA Bio Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:GBS) was last updated on 4/12/2025 by MarketBeat.com Staff From Our PartnersControversial opinion: Volume isn't enough.Don’t be fooled by volume alone — it's just one piece of the trading puzzle. High demand doesn’t matter if sup...MillPub | SponsoredDeFi Coin on Verge of Breakout!Crypto’s down — but the fundamentals aren’t. Strategic investors are using this dip to scoop up undervalued...Crypto 101 Media | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredThis almost killed Elon Musk (chilling details emerge)Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThe rotation into gold miners is on.They’re deeply undervalued gold developers with massive in-the-ground, proven resources - and now, fast-track ...Golden Portfolio | SponsoredNew “Trump” currency proposed in DCYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GBS Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GBS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GBS Stock Free GBS Stock Alerts